Lithium-induced nephrogenic diabetes insipidus treated with intravenous ketorolac.
Burke
C
C
Department of Clinical Services and Research, Medical Center of Delaware, Wilmington 19713, USA.
Fulda
G J
GJ
Castellano
J
J
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy; D018500:Diabetes Insipidus, Nephrogenic / Q000139:chemically induced* / Q000188:drug therapy*; D006801:Humans; D020910:Ketorolac; D016651:Lithium Carbonate / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D014046:Tolmetin / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016651:Lithium Carbonate; D014046:Tolmetin; D020910:Ketorolac